In vitro anti-MRSA activity of carvone with gentamicin

Experimental and Therapeutic Medicine

Volumn 7, Issue 4, 2014, Pages 891-896

  Mun, Su Hyun ^a   Kang, Ok Hwa ^a   Joung, Dae Ki ^a   Kim, Sung Bae ^a   Choi, Jang Gi ^a   Shin, Dong Won ^b   Kwon, Dong Yeul ^a  

^a Wonkwang University   (South Korea)

^b Sunchon National University   (South Korea)

Author keywords

Carvone; Gentamicin; Methicillin resistant staphylococcus aureus; Synergy

Indexed keywords

CARVONE; GENTAMICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG POTENTIATION; ENANTIOMER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

EID: 84896723224     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1498     Document Type: Article

References (24)

1. de Carvalho CCCR and da Fonseca MMR: Carvone: Why and how should one bother to produce this terpene. Food Chem 95: 413-422, 2006.
2. Grodner B and Sitkiewicz D: Enantiomers: a new problem in pharmacotherapy of depression? Psychiatr Pol 47: 511-518, 2013 (In Polish).
3. Cho IJ, Lee CW, Lee MY, Kang MR, Yun J, Oh SJ, Han SB, Lee K, Park SK, Kim HM, et al: Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents. Int Immunopharmacol 16: 457-460, 2013.
4. Krishnaiah YS and Nada A: Enantioselective penetration enhancing effect of carvone on the in vitro transdermal permeation of nicorandil. Pharm Dev Technol 17: 574-582, 2012.
5. Lehmann K, Crombie A and Singer AC: Reproducibility of a microbial river water community to self-organize upon perturbation with the natural chemical enantiomers, R-and S-carvone. FEMS Microbiol Ecol 66: 208-220, 2008.
6. Jäger W, Mayer M, Reznicek G and Buchbauer G: Percutaneous absorption of the montoterperne carvone: implication of stereoselective metabolism on blood levels. J Pharm Pharmacol 53: 637-642, 2001.
7. Jevons MP: 'Celbenin'-resistant Staphylococci. Br Med J 1: 124-125, 1961.
8. Tsubakishita S, Kuwahara-Arai K, Sasaki T and Hiramatsu K: Origin and molecular evolution of the determinant of methicillin resistance in staphylococci. Antimicrob Agents Chemother 54: 4352-4359, 2010.
9. Ragle BE and Bubeck Wardenburg J: Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 77: 2712-2718, 2009.
10. Gurieva TV, Bootsma MC and Bonten MJ: Decolonization of patients and health care workers to control nosocomial spread of methicillin-resistant Staphylococcus aureus: a simulation study. BMC Infect Dis 12: 302, 2012.
11. Clinical and Laboratory Standards Institute (CLSI): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. 7th edition. CLSI, Wayne, PA, USA, M7-A7, 2006.
12. Chang SC, Chen YC, Luh KT and Hsieh WC: In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood. Diagn Microbiol Infect Dis 23: 105-110, 1995.
13. Noble WC, Virani Z and Cree RG: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72: 195-198, 1992.
14. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H and Karaman SO: In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents 27: 224-228, 2006.
15. Moellering RC Jr: Discovering new antimicrobial agents. Int J Antimicrob Agents 37: 2-9, 2011.
16. Jung HJ and Lee DG: Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J Microbiol 46: 462-467, 2008.
17. Müller P, Alber DG, Turnbull L, Schlothauer RC, Carter DA, Whitchurch CB and Harry EJ: Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA). PLoS One 8: e57679, 2013.
18. Celenza G, Segatore B, Setacci D, Bellio P, Brisdelli F, Piovano M, Garbarino JA, Nicoletti M, Perilli M and Amicosante G: In vitro antimicrobial activity of pannarin alone and in combination with antibiotics against methicillin-resistant Staphylococcus aureus clinical isolates. Phytomedicine 19: 596-602, 2012.
19. Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT and Kwon DY: Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine 20: 714-718, 2013.
20. Nester EW, Roberts CE, Pearsall NN, Anderson DG and Nester MT: Cell walls of gram-positive bacteria, cell walls of gram-negative bacteria. In: Microbiology: A Human Perspective. Nester EW, Roberts CE and Nester MT (eds). 2nd edition. WCB/McGraw-Hill, Columbus, OH, pp58-59, 1998.
21. Uribe S, Ramirez J and Peña A: Effects of beta-pinene on yeast membrane functions. J Bacteriol 161: 1195-1200, 1985.
22. Sikkema J, de Bont JA and Poolman B: Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 59: 201-222, 1995.
23. Denyer SP and Hugo WB (eds): Biocide-induced damage to the bacterial cytoplasmic membrane. In: Mechanisms of Action of Chemical Biocides: Their Study and Exploitation. Blackwell Scientific Publications, Oxford, pp 171-187, 1991.
24. Otto CC, Cunningham TM, Hansen MR and Haydel SE: Effects of antibacterial mineral leachates on the cellular ultrastructure, morphology, and membrane integrity of Escherichia coli and methicillin-resistant Staphylococcus aureus. Ann Clin Microbiol Antimicrob 9: 26, 2010.